- Home
- PRPH vs APM Comparison
PRPH vs APM Comparison
Compare PRPH & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- APM
- Stock Information
- Founded
- PRPH 1989
- APM 2010
- Country
- PRPH United States
- APM United Kingdom
- Employees
- PRPH N/A
- APM N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- APM Health Care
- Exchange
- PRPH Nasdaq
- APM Nasdaq
- Market Cap
- PRPH 17.9M
- APM 18.9M
- IPO Year
- PRPH 1997
- APM 2018
- Fundamental
- Price
- PRPH N/A
- APM $2.41
- Analyst Decision
- PRPH
- APM
- Analyst Count
- PRPH 0
- APM 0
- Target Price
- PRPH N/A
- APM N/A
- AVG Volume (30 Days)
- PRPH 2.4M
- APM 348.5K
- Earning Date
- PRPH 11-12-2025
- APM 04-30-2025
- Dividend Yield
- PRPH N/A
- APM N/A
- EPS Growth
- PRPH N/A
- APM N/A
- EPS
- PRPH N/A
- APM N/A
- Revenue
- PRPH $5,588,000.00
- APM N/A
- Revenue This Year
- PRPH $221.82
- APM N/A
- Revenue Next Year
- PRPH N/A
- APM N/A
- P/E Ratio
- PRPH N/A
- APM N/A
- Revenue Growth
- PRPH N/A
- APM N/A
- 52 Week Low
- PRPH $0.22
- APM $0.46
- 52 Week High
- PRPH $2.50
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- PRPH 78.99
- APM 55.03
- Support Level
- PRPH $0.40
- APM $1.86
- Resistance Level
- PRPH $0.67
- APM $2.45
- Average True Range (ATR)
- PRPH 0.05
- APM 0.18
- MACD
- PRPH 0.02
- APM 0.03
- Stochastic Oscillator
- PRPH 78.72
- APM 51.90
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.